Nuveen Asset Management, LLC Accelerate Diagnostics, Inc Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $137,966 - $360,245	-255,493 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.4 - $5.15 $257,823 - $948,424	-184,160 Reduced 41.89%	255,493 $476,000
Q4 2021 Feb 14, 2022	SELL	$4.27 - $6.97 $34,787 - $56,784	-8,147 Reduced 1.82%	439,653 $2.3 Million
Q3 2021 Nov 12, 2021	SELL	$5.31 - $8.25 $301,602 - $468,591	-56,799 Reduced 11.26%	447,800 $2.61 Million
Q2 2021 Aug 16, 2021	BUY	$6.81 - $9.23 $361,256 - $489,633	53,048 Added 11.75%	504,599 $4.07 Million
Q1 2021 May 17, 2021	BUY	$7.99 - $15.0 $63,097 - $118,455	7,897 Added 1.78%	451,551 $3.76 Million
Q4 2020 May 17, 2021	SELL	$7.04 - $11.7 $132,161 - $219,644	-18,773 Reduced 4.06%	443,654 $3.36 Million
Q4 2020 Feb 16, 2021	BUY	$7.04 - $11.7 $221,612 - $368,304	31,479 Added 7.3%	462,427 $3.51 Million
Q3 2020 Nov 16, 2020	BUY	$9.98 - $18.04 $2.27 Million - $4.1 Million	227,419 Added 111.74%	430,948 $4.59 Million
Q2 2020 Aug 14, 2020	SELL	$7.49 - $15.16 $613,333 - $1.24 Million	-81,887 Reduced 28.69%	203,529 $3.09 Million
Q1 2020 May 14, 2020	SELL	$4.62 - $18.74 $19,006 - $77,096	-4,114 Reduced 1.42%	285,416 $2.38 Million
Q4 2019 Feb 14, 2020	SELL	$14.6 - $18.13 $791,334 - $982,664	-54,201 Reduced 15.77%	289,530 $4.89 Million
Q3 2019 Nov 14, 2019	SELL	$16.62 - $23.92 $1.74 Million - $2.5 Million	-104,558 Reduced 23.32%	343,731 $6.38 Million
Q2 2019 Aug 15, 2019	BUY	$17.79 - $22.88 $912,698 - $1.17 Million	51,304 Added 12.92%	448,289 $10.3 Million
Q1 2019 May 14, 2019	SELL	$11.76 - $22.15 $589,328 - $1.11 Million	-50,113 Reduced 11.21%	396,985 $8.35 Million
Q4 2018 Feb 14, 2019	SELL	$10.42 - $21.94 $802,725 - $1.69 Million	-77,037 Reduced 14.7%	447,098 $5.14 Million
Q3 2018 Nov 13, 2018	SELL	$20.4 - $24.6 $598,556 - $721,788	-29,341 Reduced 5.3%	524,135 $12 Million
Q2 2018 Aug 14, 2018	BUY	$19.02 - $24.95 $855,652 - $1.12 Million	44,987 Added 8.85%	553,476 $12.3 Million
Q1 2018 May 14, 2018	SELL	$22.55 - $29.9 $3.28 Million - $4.36 Million	-145,661 Reduced 22.27%	508,489 $11.6 Million
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $1.36 Million - $2.26 Million	-75,348 Reduced 10.33%	654,150 $0
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $15.4 Million - $18.3 Million	729,498	729,498 $16.4 Million

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account